Your browser doesn't support javascript.
loading
Gene Disruption Using CRISPR-Cas9 Technology.
Hu, Nan; Malek, Sami N.
Affiliation
  • Hu N; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Malek SN; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA. smalek@med.umich.edu.
Methods Mol Biol ; 1881: 201-209, 2019.
Article de En | MEDLINE | ID: mdl-30350208
ABSTRACT
The emergence of the clustered, regularly interspaced, short palindromic repeat (CRISPR) technology provides tools for researchers to modify genomes in a specific and efficient manner. The Type II CRISPR-Cas9 system enables gene editing by directed DNA cleavage followed by either non-homologous end joining (NHEJ) or homology-directed repair (HDR). Here, we described the use of the Type II CRISPR-Cas9 system in detail from designing the guides to analyzing the desired gene disruption events.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Ciblage de gène / Systèmes CRISPR-Cas / Édition de gène Limites: Humans Langue: En Journal: Methods Mol Biol Sujet du journal: BIOLOGIA MOLECULAR Année: 2019 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Ciblage de gène / Systèmes CRISPR-Cas / Édition de gène Limites: Humans Langue: En Journal: Methods Mol Biol Sujet du journal: BIOLOGIA MOLECULAR Année: 2019 Type de document: Article Pays d'affiliation: États-Unis d'Amérique
...